Immune system

• Health & Medicine

Weight loss condition provides clue to why some immunotherapy treatments fail

A weight loss condition frequently seen in cancer patients could provide answers as to why certain immunotherapy treatments fail in some patients. A weight loss condition frequently seen in cancer patients could provide answers as to why certain immunotherapy treatments fail in some patients.

9 November 2016

• Health & Medicine
• Science & Technology

NCRI Cancer Conference 2016: Day 3 – prostate cancer, iKnife surgery, evolving tumours and more

Here are our highlights from day 3 of the NCRI Cancer Conference, including personalised treatment for prostate cancer, and new surgery tech. Here are our highlights from day 3 of the NCRI Cancer Conference, including personalised treatment for prostate cancer, and new surgery tech.

8 November 2016

• Health & Medicine

Immune cells may become ‘exhausted’ during immunotherapy

Specialised immune cells can become ‘exhausted’ following immunotherapy to treat cancer, limiting the treatment’s effectiveness in some people. Specialised immune cells can become ‘exhausted’ following immunotherapy to treat cancer, limiting the treatment’s effectiveness in some people.

28 October 2016

• Science & Technology

Zebrafish reveal brain tumours' secret ally

Our scientists have made it possible to see the unexpected relationship between immune cells and brain tumour cells. Our scientists have made it possible to see the unexpected relationship between immune cells and brain tumour cells.

27 October 2016

• Science & Technology

How a little known organ could protect people who’ve had stem cell transplants

Our Stand Up To Cancer-funded researchers in Birmingham are turning their immune cell knowledge into ways to tackle infection after treatment. Our Stand Up To Cancer-funded researchers in Birmingham are turning their immune cell knowledge into ways to tackle infection after treatment.

18 October 2016

• For Researchers

A new era for pancreatic cancer: The Dream Team

We catch up with Professor Gerard Evan, a cancer genetics expert in Cambridge, to hear about his Stand Up To Cancer-funded work on pancreatic cancer. We catch up with Professor Gerard Evan, a cancer genetics expert in Cambridge, to hear about his Stand Up To Cancer-funded work on pancreatic cancer.

17 October 2016

• Science & Technology
• Health & Medicine

The trans-Atlantic quest to find a winning combination of cancer drugs

An exciting new partnership will see a combination of drugs tested in mesothelioma, lung and pancreatic cancers for the first time. An exciting new partnership will see a combination of drugs tested in mesothelioma, lung and pancreatic cancers for the first time.

30 September 2016

• Science & Technology
• Health & Medicine

Why cancer is (still) more than just ‘bad luck’

New research has uncovered a possible explanation for why some cancers are more common than others, we explore the details. New research has uncovered a possible explanation for why some cancers are more common than others, we explore the details.

25 August 2016

• Health & Medicine
• Science & Technology

Building tumours in the lab – a how to guide

Our scientists in London are taking apart tumours and rebuilding artificial versions in the lab to help test the latest treatments. Our scientists in London are taking apart tumours and rebuilding artificial versions in the lab to help test the latest treatments.

4 July 2016

• Science & Technology
• Health & Medicine

ASCO 2016: will fine-tuning treatments require redefined tumours?

From immunotherapy to targeted cancer treatment, here's our round up of the big news from the annual ASCO conference. From immunotherapy to targeted cancer treatment, here's our round up of the big news from the annual ASCO conference.

15 June 2016